// App-Quantinova.ai

: Incidence, Type, and Management of Venous and Arterial Thrombosis during Ibrutinib Treatment

Researchers

Presenter

  • Elizabeth Kander

Principal Investigators

  • Qiuhong Zhao

  • Tracy Wiczer

  • John C. Byrd

  • Jennifer A. Woyach

  • Farrukh T. Awan

  • Kerry A. Rogers

  • Tzu-Fei Wang

Medical Centers

  • Division of Human Genetics, The Ohio State University, Columbus, OH

  • Hematology Oncology Fellowship, The Ohio State University, Columbus, OH

  • Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • Department of Pathology, The Ohio State University, Columbus, OH

  • Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • Department of Internal Medicine, Division of Hematology, Wexner Medical Center, The Ohio State University, Columbus, OH

  • The Ohio State Univerisity, Columbus, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Ibrutinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved